Inventor · disambiguated record
Jason Mastaitis
Also filed as: MASTAITIS JASON
5 granted patents·4 pending applications·6 citations·filing 2017–2025
71Inventor score
Files withREGENERON PHARMA9
Top patents by PatentIndex Score
9 records- 0193US11820826B2Anti-NPR1 antibodies and uses thereofREGENERON PHARMA·Filed 2022·Granted Nov 21, 2023·2 cites·14 claims
- 0288US11306148B2Anti-NPR1 antibodies and uses thereofREGENERON PHARMA·Filed 2019·Granted Apr 19, 2022·3 cites·11 claims
- 0382US2024309103A1Anti-npr1 antibodies and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0481US2024059780A1Anti-npr1 antibodies and uses thereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0580US10548302B2Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophyREGENERON PHARMA·Filed 2017·Granted Feb 4, 2020·1 cites·30 claims
- 0676US2025304656A1Nucleic acids encoding anchor modified antibodies and uses thereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0774US12371475B2Nucleic acids encoding anchor modified antibodies and uses thereofREGENERON PHARMA·Filed 2021·Granted Jul 29, 2025·0 cites·27 claims
- 0868US11730150B2Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophyREGENERON PHARMA·Filed 2019·Granted Aug 22, 2023·0 cites·20 claims
- 0965US2024199728A1Methods of treating obesity, diabetes, and liver dysfunctionREGENERON PHARMA·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason Mastaitis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →